These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7257481)

  • 21. French comment on article: Prospective evaluation of bacteremia rates and infectious complications among patients undergoing single-operator choledochoscopy during ERCP.
    Endoscopy; 2016 May; 48(5):505. PubMed ID: 27115926
    [No Abstract]   [Full Text] [Related]  

  • 22. Complications related to diagnostic and therapeutic endoscopic retrograde cholangiopancreatography.
    Aliperti G
    Gastrointest Endosc Clin N Am; 1996 Apr; 6(2):379-407. PubMed ID: 8673333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, risk factors, and prevention of post-ERCP pancreatitis.
    Cooper ST; Slivka A
    Gastroenterol Clin North Am; 2007 Jun; 36(2):259-76, vii-viii. PubMed ID: 17533078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Is it useful to add gentamycin to contrast media in endoscopic retrograde cholangiopancreatography? Prospective evaluation of 330 cases].
    Pugliese V; Saccomanno S; Bonelli L; Aste H
    Minerva Dietol Gastroenterol; 1986; 32(2):149-56. PubMed ID: 3736962
    [No Abstract]   [Full Text] [Related]  

  • 25. Infection after ERCP, and antibiotic prophylaxis: a sequential quality-improvement approach over 11 years.
    Cotton PB; Connor P; Rawls E; Romagnuolo J
    Gastrointest Endosc; 2008 Mar; 67(3):471-5. PubMed ID: 18061594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy Versus effectiveness of octreotide in the prophylaxis of post-ERCP pancreatitis.
    Andriulli A; Loperfido S
    Am J Gastroenterol; 2007 Jul; 102(7):1539. PubMed ID: 17593163
    [No Abstract]   [Full Text] [Related]  

  • 27. [Complications in diagnostic and therapeutic endoscopic cholangiopancreatography. Prospective study].
    Güitrón-Cantú A; Adalid-Martínez R; Gutiérrez-Bermúdez JA; Nieves-Rentería A; Alvarez-Valdés G
    Rev Gastroenterol Mex; 2007; 72(3):227-35. PubMed ID: 18402212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylaxis of post-ERCP pancreatic complications with gabexate.
    Piscaglia F; Righini R; Tewelde AG
    Dig Liver Dis; 2007 Mar; 39(3):291; author reply 291. PubMed ID: 17267312
    [No Abstract]   [Full Text] [Related]  

  • 29. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks.
    Andriulli A; Forlano R; Napolitano G; Conoscitore P; Caruso N; Pilotto A; Di Sebastiano PL; Leandro G
    Digestion; 2007; 75(2-3):156-63. PubMed ID: 17684365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoscopic retrograde cholangiopancreatography in children: A surgeon's perspective.
    Prasil P; Laberge JM; Barkun A; Flageole H
    J Pediatr Surg; 2001 May; 36(5):733-5. PubMed ID: 11329577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indomethacin for post-ERCP pancreatitis prophylaxis: another attempt at the Holy Grail.
    Wagh MS; Sherman S
    Am J Gastroenterol; 2007 May; 102(5):984-6. PubMed ID: 17489783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complications of ERCP: ethical obligations and legal consequences.
    Rácz I; Rejchrt S; Hassan M
    Dig Dis; 2008; 26(1):49-55. PubMed ID: 18600016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infectious complications following endoscopic retrograde cholangiopancreatography: an automated surveillance system for detecting postprocedure bacteremia.
    Anderson DJ; Shimpi RA; McDonald JR; Branch MS; Kanafani ZA; Harger J; Ely TM; Sexton DJ; Kaye KS
    Am J Infect Control; 2008 Oct; 36(8):592-4. PubMed ID: 18926314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic prophylaxis for ERCP: a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis.
    Mehal WZ; Culshaw KD; Tillotson GS; Chapman RW
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):841-5. PubMed ID: 8574715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse outcomes of endoscopic retrograde cholangiopancreatography.
    Freeman ML
    Rev Gastroenterol Disord; 2002; 2(4):147-68. PubMed ID: 12481167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic retrograde cholangiopancreatography in the elderly.
    Avila-Funes JA; Montaño-Loza A; Zepeda-Gómez S; Meza-Junco J; Melano-Carranza E; Valdovinos-Andraca F; Valdovinos-Díaz MA; Ponce de León-Rosales S
    Rev Invest Clin; 2005; 57(5):666-70. PubMed ID: 16419460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Complications of endoscopic procedures].
    Jałocha L; Wojtuń S; Gil J
    Pol Merkur Lekarski; 2004; 17 Suppl 1():87-9. PubMed ID: 15603358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic antibiotics cannot prevent endoscopic retrograde cholangiopancreatography-induced cholangitis: a meta-analysis.
    Bai Y; Gao F; Gao J; Zou DW; Li ZS
    Pancreas; 2009 Mar; 38(2):126-30. PubMed ID: 19238021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rational use of antibiotics in intensive care units (author's transl)].
    Gjurasin M; Vrhovac B; Bakran I
    Lijec Vjesn; 1978 Oct; 100(10):666-8. PubMed ID: 745511
    [No Abstract]   [Full Text] [Related]  

  • 40. Silent myocardial ischaemia during endoscopic retrograde cholangiopancreatography.
    Johnston SD; McKenna A; Tham TC
    Endoscopy; 2003 Dec; 35(12):1039-42. PubMed ID: 14648418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.